School of Stomatology,Harbin Medical University,Harbin 150000,China.
Department of Oral and Maxillofacial,The First Affilitated Hospital Of Harbin Medical University, Harbin 150000,China.
Asian Pac J Cancer Prev. 2024 Mar 1;25(3):909-919. doi: 10.31557/APJCP.2024.25.3.909.
Head and neck squamous cell carcinoma (HNSCC) is one of the world's eight most common malignancies and a severe hazard to human health. Transmembrane protein 208 (TMEM208) has been reported to be associated with autophagy,which is strongly tied to the onset and development of numerous illnesses, including cancer. For this reason, we investigated the expression and prognostic significance of TMEM208 in HNSCC.
To explore the role and molecular mechanism of this gene in HNSCC, we performed a comprehensive analysis of the TMEM208 gene, including gene expression analysis, prognostic analysis, and immune infiltration analysis using the UALCAN, HPA, CVCDAP, DAVID, TIMER, CIBERSORTx, TISIDB, and cBioPortal online databases. It was further validated by in vitro cell culture.
Analysis of TCGA data showed that TMEM208 was highly expressed in HNSCC (P < 0.01) and significantly correlated with several clinicopathologic features, and in vitro cellular assays demonstrated that TMEM208 was highly expressed in multiple squamous carcinoma cell lines. Survival analysis showed that high expression of TMEM208 decreased OS (P=0.0088), PFI (P=0.0062), and DSS (P=0.0036) in HNSCC patients. cox regression analysis indicated that high expression of TMEM208 was an independent risk factor for OS in HNSCC patients (P<0.05). In addition, functional enrichment analysis showed that TMEM208 was closely associated with translation, ribosomal and mitochondrial functions, and GSVA analysis showed that TMEM208 was negatively correlated with a variety of immune cell differentiation in HNSCC, with a statistically significant difference. Immunocorrelation analysis showed that TMEM208 could affect immune cell infiltration in HNSCC; in addition, TMEM208 correlated with CD24, CD276, LAG3, and HVEM.
In conclusion, TMEM208 holds promise as a prognostic indicator for HNSCC and is closely related to ICI treatment.
头颈部鳞状细胞癌(HNSCC)是世界上八种最常见的恶性肿瘤之一,严重危害人类健康。跨膜蛋白 208(TMEM208)已被报道与自噬有关,自噬与许多疾病的发生和发展密切相关,包括癌症。因此,我们研究了 TMEM208 在 HNSCC 中的表达及其预后意义。
为了探讨该基因在 HNSCC 中的作用和分子机制,我们使用 UALCAN、HPA、CVCDAP、DAVID、TIMER、CIBERSORTx、TISIDB 和 cBioPortal 在线数据库对 TMEM208 基因进行了全面分析,包括基因表达分析、预后分析和免疫浸润分析。进一步通过体外细胞培养进行验证。
TCGA 数据分析显示,TMEM208 在 HNSCC 中高表达(P<0.01),并与多种临床病理特征显著相关,体外细胞实验表明 TMEM208 在多种鳞状癌细胞系中高表达。生存分析显示,TMEM208 高表达降低了 HNSCC 患者的 OS(P=0.0088)、PFI(P=0.0062)和 DSS(P=0.0036)。cox 回归分析表明,TMEM208 高表达是 HNSCC 患者 OS 的独立危险因素(P<0.05)。此外,功能富集分析表明 TMEM208 与翻译、核糖体和线粒体功能密切相关,GSVA 分析表明 TMEM208 与 HNSCC 中多种免疫细胞分化呈负相关,差异有统计学意义。免疫相关性分析表明,TMEM208 可影响 HNSCC 中免疫细胞浸润;此外,TMEM208 与 CD24、CD276、LAG3 和 HVEM 相关。
总之,TMEM208 有望成为 HNSCC 的预后指标,与免疫检查点抑制剂(ICI)治疗密切相关。